<DOC>
	<DOCNO>NCT00743561</DOCNO>
	<brief_summary>The purpose study determine whether ambulatory polygraphy short hospitalization neurology unit performance inpatient polysomnography , actual gold standard , diagnosis sleep apnea patient suffer multiple system atrophy ( MSA ) .</brief_summary>
	<brief_title>Assessment Ambulatory Polygraphy Detection Sleep Apnea Multiple System Atrophy ( SAMSA )</brief_title>
	<detailed_description>MSA patient frequently show sleep apnea . Inpatient polysomnography currently gold standard diagnosis sleep apnea . However , limited availability high cost restrain systematic screening MSA patient . In contrast , ambulatory polygraphy easy achieve short hospitalization neurology unit patient 's home . Its validity MSA unknown . The purpose study ass whether ambulatory polygraphy realize short hospitalization neurology unit performance inpatient polysomnography diagnosis sleep apnea MSA patient . Polygraphy recording also do daytime characterize diurnal respiratory disturbance . Principal Objective : To assess performance ambulatory polygraphy diagnosis sleep apnea MSA patient comparison polysomnography ( reference test ) . Secondary Objectives : To assess performance ambulatory polygraphy diagnosis sleep apnea comparison polysomnography two subgroup MSA patient : one high risk one low risk accord result Berlin Questionnaire Epworth Sleepiness Scale . To assess inter-rater agreement ambulatory polygraphy . To assess association sleep apnea ( ) severity MSA , ( ii ) quality life , ( iii ) quality sleep , ( iv ) presence depression . To assess association severity sleep apnea ( ) severity MSA , ( ii ) quality life , ( iii ) quality sleep ( iv ) presence depression . To assess diurnal respiratory disturbance MSA perform polygraphical recording daytime . To assess association diurnal respiratory disturbance MSA ( ) severity MSA ( ii ) quality life . Study design : Cross-sectional prospective study ( delay one month ambulatory polygraphy short hospitalization neurology unit inpatient polysomnography ) . Each test carry interpreted blind test . Study plan : Visit Selection ( V0 ) - Verification eligibility - Study related information Visit inclusion ( From 0 90 day selection ) - Verification eligibility - Diagnosis criterion - Oral inform consent patient representative - Clinical examination use UMSARS , MMSE , Berlin Questionnaire , Epworth Sleepiness Scale , PSQI , MSA-QoL , SF-36 Beck Depression Inventory - Ambulatory polygraphy short hospitalization neurology unit Visit follow-up ( V2 , 1 month Â± 5 day V1 ) - Clinical examination use UMSARS , Berlin Questionnaire Epworth Sleepiness Scale - Inpatient polysomnography Number subject : 30 patient ( estimation 15 patient high risk sleep apnea 15 patient low risk ) .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Multiple System Atrophy</mesh_term>
	<mesh_term>Shy-Drager Syndrome</mesh_term>
	<criteria>Diagnosis `` probable '' MSA accord current consensus criterion ( Gilman et al . 1999 , PMID 10223419 ) Age 3080 year Oral inform consent patient representative Patient require hospitalization neurology unit Progressive cancer Significant cognitive impairment ( MMSE &lt; 24 ) Sleep apnea Respiratory disorder Less one year since previous polysomnography ambulatory polygraphy</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>MSA</keyword>
	<keyword>sleep apnea</keyword>
	<keyword>ambulatory polygraphy</keyword>
	<keyword>polysomnography</keyword>
</DOC>